Helping teens with type 1 diabetes improve diabetes control with MyDiaText

PHILADELPHIA (September 3, 2020) – Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM). The challenges of managing multiple doses of daily insulin administration, blood glucose monitoring, dietary and exercise requirements, can make self-care difficult and complicate outcomes. Adolescents with T1DM often have poorer diabetes outcomes than others, indicating that glucose control is difficult for them to maintain.

Data show that 88 percent of teens own a cell phone and more than 50 percent text with friends daily. Therefore, mobile technolgoies could be a key to helping adolescents more fully engage with their T1DM self-care.

In an article in the Journal of Diabetes Science and Technology, researchers outline their study combining text messaging with MyDiaText? and financial incentives designed to help improve outcomes for adolescents with T1DM. The study results showed persistent engagement with and potential for increase in self-care using this intervention. MyDiaText? was developed in 2012 by a collaboration with the School of Nursing, the School of Engineering and Applied Sciences and Children’s Hospital of Philadelphia.

“We have demonstrated that text messaging is a promising method by which to engage adolescents with T1D who have suboptimal control, in their self-care and deserves further investigation. There remains a need to develop a digital health intervention that significantly impacts glycemic control in this population” writes Terri H. Lipman, PhD, CRNP, FAAN, the Miriam Stirl Endowed Term Professor of Nutrition, Professor of Nursing of Children and Assistant Dean for Community Engagement at the University of Pennsylvania School of Nursing (Penn Nursing). Lipman is the senior author of the article. The article, “A Text Messaging Intervention with Financial Incentive for Adolescents with Type 1 Diabetes” is set for publicaiton this fall but is now available online here.

###

Coauthors of the article include: Tara Kaushal, MD, MSHP and Lori Laffel, MD, MPH, both of the Joslin Diabetes Center; Lorraine E. Levitt Katz, MD, Janet Joseph, BA, Michelle Marowitz, CRNP, and Daniel Atkins, BS, all of the Children’s Hospital of Philadelphia; Knashawn H. Morales, ScD of the University of Pennsylvania Perelman School of Medicine; Dean Ritter, BA, of FreedomPay, Inc.; and Reid Simon, BS, of the National Center for Advancing Translational Sciences. The research was supported by the Community Engagement Research Core, Clinical & Translational Science Award in the Center for Public Health Initiatives (CPHI) at the University of Pennsylvania supported by the NIH /NCATS award UL1TR001878; NIH/NIDDK Pediatric Endocrinology Fellowship Training Award 2T32DK063688-CHOP; CHOP Research Information Services, NIH grants 5K12DK094721-09 and P30DK036836.

The University of Pennsylvania School of Nursing is one of the world’s leading schools of nursing. For the fifth year in a row, it is ranked the #1 nursing school in the world by QS University and is consistently ranked highly in the U.S. News & World Report annual list of best graduate schools. Penn Nursing is currently ranked # 1 in funding from the National Institutes of Health, among other schools of nursing, for the third consecutive year. Penn Nursing prepares nurse scientists and nurse leaders to meet the health needs of a global society through innovation in research, education, and practice. Follow Penn Nursing on: Facebook, Twitter, LinkedIn, & Instagram.